Clinical Applications of Recombinant Human Granulocyte Colony-Stimulating Factor in Reproductive Medicine: Expert Consensus
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 1
Abstract
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is primarily indicated for neutropenia caused by various etiologies in clinical practice. Recently, it has been shown to have some therapeutic effects and be safe for mother and child in some clinical research and treatment of reproductive diseases. However, until now, there is currently no authoritative expert consensus and guidelines published. To standardize the research and rational application of rhG-CSF in reproductive medicine-related fields, the Committee on Reproductive Immunity of the China Association for Promotion of Health Science and Technology (the Committee) organized experts from relevant disciplines to formulate the Expert Consensus, which is based on the latest international basic study, clinical research evidence, and the national situation of China. According to evidence-based data, recommendations were established on the applicable population, medication methods, and timing of discontinuation of rhG-CSF in reproductive medicine. It is recommended that rhG-CSF could be applied in patients with thin endometrium, which was ineffective to standard treatments, in unexplained recurrent spontaneous abortion (RSA), in unexplained recurrent implantation failure (RIF), and could attempt to be applied in unexplained RSA with the slow rise of human chorionic gonadotropin and embryo growth retardation. After the patient signs the super instruction for medication and treatment informed consent form, rhG-CSF can only be used for patients with thin endometrium, unexplained recurrent miscarriage, unexplained repeated embryo implantation failure, slow rise of human chorionic gonadotropin. Comprehensive communication between gynecologists and obstetricians and patients before therapy is essential according to that the rhG-CSF treatment would be inefficient when a genetic abnormality, embryo abnormality, heterotopic pregnancy and other unknown disorder exist.
Authors and Affiliations
Jianming Chen, Yazhong Ji, Zhaohui Zhang
Keywords
Related Articles
- EP ID EP740146
- DOI 10.54457/DR.202301008
- Views 80
- Downloads 0
Maintenance Mechanism of Chronic HBV Infection and the Strategy for Functional Cure
Chronic Hepatitis B virus (HBV) infection is a leading cause of chronic hepatitis, liver cirrhosis (LC), liver failure (LF) and hepatocellular carcinoma (HCC) in China. In addition to a 3.2 kb partially double-stranded r...
ADAMTS Proteases: Their Multifaceted Role in the Regulation of Cancer Metastasis
Cancer leads to nearly 10 million deaths worldwide per year. The tumour microenvironment (TME) is fundamental for tumour growth and progression. A key component of the TME, the extracellular matrix (ECM) has recently bec...
Patients Would Accept Antibiotics for Appendicitis if Recommended by Their Surgeon – An Interview Study
Background Antibiotics as treatment for uncomplicated appendicitis has been studied intensely in terms of complications and recurrence of appendicitis to assess if antibiotics could replace appendectomy in selected pati...
Angioimmunoblastic T Cell Lymphoma Complicated by Cirrhosis Decompensation
A 55-year-old male with a history of hepatitis B was hospitalized for persistent cough, fever, rash, and abdominal bloating. Despite treatment for suspected respiratory infection with multiple antibiotics, his symptoms w...
Hepatic Paragonimiasis: A Case Report and Literature Review
Paragonimiasis is a parasitic disease caused by paragnonimus, which primarily caused infection in the lung, and ectopic infection was less common. Ectopic paragonimiasis are more likely to be misdiagnosed as malignancy o...